Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
|Articles|April 12, 2013
DIOSNA Dierks & Söhne GmbH - Granulationline CGS
Advertisement
The CGS concept provides optimal integration of the process steps of mixing, granulating and drying. The outlet of the mixer-granulator is directly linked to the inlet of the fluid bed dryer, eliminating long transfer pipes.
Installation expenditure for the CGS is low. Mixer and dryer are supported by one common frame which makes additional framework unnecessary.
The CGS concept can incorporate an integrated explosion protection concept. The individual processing units of mixer, wet mill and dryer will then be designed to be 12 bar pressure shock resistant.
Due to the compact installation, the floor space required by the CGS plant is very small. This fact is not only important for existing plants with limited available space, but also for new plants which allows clean room space to be reduced.
All connection lines of the CGS from feeding the mixer to discharging the dryer are integrated into the automatic cleaning system. Due to well planned accessibility of all areas the supply lines can be connected in minimal time.
Website:
E-mail:
Advertisement
Related to this article
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Advertisement
Advertisement